It has been noted that the occurrence of use errors, also called as human error, increases the number and severity of incidents related to the use of medical devices. Use errors typically occur when...
Recent Posts
With their next-generation innovation, Synoste aims to renew surgical treatment related to bone deformities. Innokas Medical is involved in this mission by being one of Synoste's co-creation partners...
Healthcare technology is one of the largest high-tech export segments of Finnish industry, and it continues to grow strongly year after year. In addition to growth, the industry is evolving with...
Innokas Medical and Serres are sponsoring one of the 14 guest rooms of Ronald McDonald House (RMH) Charities in Meilahti, Helsinki. Sponsorship helps covering the costs of operating the House,...
WellO2, innovation developed by the Finnish company WellO2 Oy (formerly known as Hapella Oy), is a breathing exercise device that strengthens and cleanses the lungs. The mission of the company is to...
The collaborative consortium has received a significant funding from Business Finland. This two-year Stroke-DATA -project, which is one part of Business Finland’s Smart Life program, is carried out...
Norwegian healthtech innovator Augere Medical AS has selected Innokas Medical as their co-creation partner to offer quality and regulatory as well as design and development support to bring their...
Professional Quality and Regulatory Services guiding You to master Your Medical Device compliance journey!
Do you feel there's tons of process guidance out there but you don't understand which...
Danish company Samplix ApS selected Innokas Medical to co-create the novel Xdrop™ instrument for droplet-based PCR-free enrichment of genomic regions.
